DEWB posts positive result following the sale of EPIDAUROS

- Return to new investment activity
- Continuation of the focus on photonics and sensor systems
- Assets under management increased to more than 70 million euros

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

companies/Interim report

Jena, 9 November 2007 (euro adhoc) - In the first nine months of 2007
Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (DEWB)
generated 6.6 million euros from the sale of shares in companies. The
gross result of the investment business totaled 1.2 million euros
with the operating result (EBIT) and result after taxes coming in at
0.1 million euros. This corresponds to earnings per share of 0.01
euros. In the same period for the previous year income from the sale
of shares totaled 9.5 million euros. The EBIT and result after taxes
were 1.4 million euros respectively. However, this comparison between
periods is of only minimal relevance due to the significant
fluctuations in sales and earnings, a characteristic feature of the
investment business.

In addition to the consistent further development of its investments,
over recent months DEWB has taken a number of key measures for its
own development. The sale of EPIDAUROS Biotechnologie AG is the first
of the heralded exits. The sale represents part of the strategy of
focusing the portfolio on the core areas of expertise, photonics and
sensor systems. "DEWB will be pressing ahead with the realignment of
the portfolio in order to further optimize its value. We are
currently conducting sales negotiations with interested parties for
other investment holdings from the areas of IT and biotechnology.
These are fields from which we intend to gradually withdraw so that
in future we can invest in photonics and sensor system companies
which offer highly promising prospects", explains Bertram Köhler,
Member of the DEWB AG Management Board.

DEWB´s investment in the Jena-based Zenteris GmbH represents its
return to new investment activity following a three-year break. Over
recent years the funds have been used for the portfolio company´s
development and to reduce its debt. Investments were made exclusively
in existing portfolio companies. "The new commitment to Zenteris was
a transaction that points the way ahead: DEWB has made an active
return to new business. We are currently looking at a series of
additional, very attractive investment opportunities within the area
of our technology focus. Over the months ahead we will be
significantly strengthening our new investment activity and
establishing DEWB as a leading, independent capital provider for
photonics and sensor systems within the German-speaking region", says
Köhler in summary.

In order to provide the financial resources required for this the
company raised additional capital through a convertible bond in
October. The bond, with an issue volume of 20 million euros, was
clearly over-subscribed and placed both with shareholders as well as
new international investors. DEWB´s assets under management have
therefore increased to more than 70 million euros. The aim is to
increase this figure to more than 100 million euros by 2010 by
enhancing the value of the portfolio investments.

For more detailed information on the course of business during the
first nine months of 2007 please refer to our interim report as at
September 30, 2007 which is published today and is available on our
Internet site: www.dewb-vc.com.

About DEWB Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
(DEWB AG, Prime Standard, Securities No.: 804100 / ISIN:
DE0008041005) is an investment company that specialises in young and
established medium-sized companies. The focus of our investments is
on strong growth companies from the areas of photonics and sensor
systems for which we provide support through shareholders´ equity,
expertise in corporate development and our sector network. Our
regional focus lies in the German speaking countries (D, A, CH).
Since 1997 we have invested more than 300 million Euros in 53
companies and realized more than 400 million Euros through 33 exits,
eight of which were in the form of IPOs. The company is located in
Jena, one of the most successful technology and science regions in
Germany, with a long tradition in the field of optical technologies
and one of the most important European centres for photonics.

end of announcement euro adhoc 09.11.2007 08:33:15
--------------------------------------------------------------------------------

ots Originaltext: Deutsche Effecten- und Wechsel-Beteiligungsges. AG (DEWB)
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Marco Scheidler
Tel.: +49 (0) 3641 573-3600
E-Mail: marco.scheidler@dewb-vc.com

Branche: Financial & Business Services
ISIN: DE0008041005
WKN: 804100
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse München / free trade


	hier anmelden...